Annual EBITDA
-$78.78 M
-$11.06 M-16.34%
December 31, 2023
Summary
- As of February 8, 2025, RLYB annual EBITDA is -$78.78 million, with the most recent change of -$11.06 million (-16.34%) on December 31, 2023.
- During the last 3 years, RLYB annual EBITDA has fallen by -$53.95 million (-217.30%).
- RLYB annual EBITDA is now -352.90% below its all-time high of -$17.39 million, reached on December 31, 2019.
Performance
RLYB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$12.03 M
+$4.97 M+29.22%
September 30, 2024
Summary
- As of February 8, 2025, RLYB quarterly EBITDA is -$12.03 million, with the most recent change of +$4.97 million (+29.22%) on September 30, 2024.
- Over the past year, RLYB quarterly EBITDA has increased by +$7.29 million (+37.73%).
- RLYB quarterly EBITDA is now -223.15% below its all-time high of -$3.72 million, reached on March 31, 2020.
Performance
RLYB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$69.86 M
+$7.29 M+9.45%
September 30, 2024
Summary
- As of February 8, 2025, RLYB TTM EBITDA is -$69.86 million, with the most recent change of +$7.29 million (+9.45%) on September 30, 2024.
- Over the past year, RLYB TTM EBITDA has increased by +$4.89 million (+6.55%).
- RLYB TTM EBITDA is now -1776.02% below its all-time high of -$3.72 million, reached on March 31, 2020.
Performance
RLYB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
RLYB EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -16.3% | +37.7% | +6.5% |
| 3 y3 years | -217.3% | +29.4% | -3.2% |
| 5 y5 years | -352.9% | +29.4% | -3.2% |
RLYB EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -73.6% | at low | at high | +42.9% | -53.9% | +12.9% |
| 5 y | 5-year | -352.9% | at low | -223.2% | +42.9% | -1776.0% | +12.9% |
| alltime | all time | -352.9% | at low | -223.2% | +42.9% | -1776.0% | +12.9% |
Rallybio EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$12.03 M(-29.2%) | -$69.86 M(-9.5%) |
| Jun 2024 | - | -$17.00 M(-13.9%) | -$77.16 M(-3.8%) |
| Mar 2024 | - | -$19.75 M(-6.3%) | -$80.20 M(+1.8%) |
| Dec 2023 | -$78.78 M(+16.3%) | -$21.08 M(+9.1%) | -$78.78 M(+5.4%) |
| Sep 2023 | - | -$19.33 M(-3.6%) | -$74.76 M(+0.7%) |
| Jun 2023 | - | -$20.05 M(+9.3%) | -$74.25 M(+3.4%) |
| Mar 2023 | - | -$18.34 M(+7.5%) | -$71.78 M(+6.0%) |
| Dec 2022 | -$67.72 M | -$17.05 M(-9.4%) | -$67.72 M(+7.8%) |
| Sep 2022 | - | -$18.82 M(+7.1%) | -$62.82 M(+16.7%) |
| Jun 2022 | - | -$17.57 M(+23.1%) | -$53.84 M(+14.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$14.28 M(+17.4%) | -$46.91 M(+3.3%) |
| Dec 2021 | -$45.39 M(+82.8%) | -$12.16 M(+23.6%) | -$45.39 M(+5.1%) |
| Sep 2021 | - | -$9.84 M(-7.5%) | -$43.20 M(+8.1%) |
| Jun 2021 | - | -$10.63 M(-16.7%) | -$39.97 M(+18.0%) |
| Mar 2021 | - | -$12.76 M(+28.0%) | -$33.87 M(+36.4%) |
| Dec 2020 | -$24.83 M(+42.7%) | -$9.97 M(+51.1%) | -$24.83 M(+67.1%) |
| Sep 2020 | - | -$6.60 M(+45.7%) | -$14.86 M(+80.0%) |
| Jun 2020 | - | -$4.53 M(+21.7%) | -$8.26 M(+121.7%) |
| Mar 2020 | - | -$3.72 M | -$3.72 M |
| Dec 2019 | -$17.39 M | - | - |
FAQ
- What is Rallybio annual EBITDA?
- What is the all time high annual EBITDA for Rallybio?
- What is Rallybio annual EBITDA year-on-year change?
- What is Rallybio quarterly EBITDA?
- What is the all time high quarterly EBITDA for Rallybio?
- What is Rallybio quarterly EBITDA year-on-year change?
- What is Rallybio TTM EBITDA?
- What is the all time high TTM EBITDA for Rallybio?
- What is Rallybio TTM EBITDA year-on-year change?
What is Rallybio annual EBITDA?
The current annual EBITDA of RLYB is -$78.78 M
What is the all time high annual EBITDA for Rallybio?
Rallybio all-time high annual EBITDA is -$17.39 M
What is Rallybio annual EBITDA year-on-year change?
Over the past year, RLYB annual EBITDA has changed by -$11.06 M (-16.34%)
What is Rallybio quarterly EBITDA?
The current quarterly EBITDA of RLYB is -$12.03 M
What is the all time high quarterly EBITDA for Rallybio?
Rallybio all-time high quarterly EBITDA is -$3.72 M
What is Rallybio quarterly EBITDA year-on-year change?
Over the past year, RLYB quarterly EBITDA has changed by +$7.29 M (+37.73%)
What is Rallybio TTM EBITDA?
The current TTM EBITDA of RLYB is -$69.86 M
What is the all time high TTM EBITDA for Rallybio?
Rallybio all-time high TTM EBITDA is -$3.72 M
What is Rallybio TTM EBITDA year-on-year change?
Over the past year, RLYB TTM EBITDA has changed by +$4.89 M (+6.55%)